Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Lim

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|August 1, 1995
Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombinK Håkansson, A Tulinsky, M M Abelman, et al.
Molecular Pathology : MP|December 3, 2003
Validation of cDNA microarray gene expression data obtained from linearly amplified RNAS D Jenson, R S Robetorye, S D Bohling, et al.
Leukemia|November 15, 2016
Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complexG Palacios, T I Shaw, Y Li, et al.
Cell Death and Differentiation|July 5, 2014
Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survivalX Chen, A A Sahasrabuddhe, P Szankasi, et al.
Biochemistry|September 2, 1998
Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydesR Krishnan, E Zhang, K Hakansson, et al.
Veterinary Immunology and Immunopathology|April 9, 2025
Evaluation of clinical and immunological responses to recombinant canine interleukin-15 therapy in dogs with cancer: A pilot studyY J Lim, M S Lim, J J Lee, et al.
Scandinavian Journal of Immunology|November 7, 2012
Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cellsE C Hwang, M-S Lim, C-M Im, et al.
Journal of Clinical Pharmacy and Therapeutics|January 7, 2011
Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokineticsH W Lee, M-s Lim, J Lee, et al.
Journal of Clinical Pharmacy and Therapeutics|July 7, 2011
In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoformsH W Lee, D W Kim, P B Phapale, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosisH W Lee, D W Kim, J H Park, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|August 1, 1995
Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombinK Håkansson, A Tulinsky, M M Abelman, et al.
Molecular Pathology : MP|December 3, 2003
Validation of cDNA microarray gene expression data obtained from linearly amplified RNAS D Jenson, R S Robetorye, S D Bohling, et al.
Leukemia|November 15, 2016
Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complexG Palacios, T I Shaw, Y Li, et al.
Cell Death and Differentiation|July 5, 2014
Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survivalX Chen, A A Sahasrabuddhe, P Szankasi, et al.
Biochemistry|September 2, 1998
Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydesR Krishnan, E Zhang, K Hakansson, et al.
Veterinary Immunology and Immunopathology|April 9, 2025
Evaluation of clinical and immunological responses to recombinant canine interleukin-15 therapy in dogs with cancer: A pilot studyY J Lim, M S Lim, J J Lee, et al.
Scandinavian Journal of Immunology|November 7, 2012
Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cellsE C Hwang, M-S Lim, C-M Im, et al.
Journal of Clinical Pharmacy and Therapeutics|January 7, 2011
Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokineticsH W Lee, M-s Lim, J Lee, et al.
Journal of Clinical Pharmacy and Therapeutics|July 7, 2011
In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoformsH W Lee, D W Kim, P B Phapale, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosisH W Lee, D W Kim, J H Park, et al.
Pageof 7